AbbVie ABBV Finance Lease Liabilities
Discontinued — last reported Q4 '25
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by AbbVie in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The official record: AbbVie’s 10-K, filed February 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbbVie's finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbbVie's finance lease liabilities?
- AbbVie (ABBV) reported finance lease liabilities of $22M in Q4 2025.
- How has AbbVie's finance lease liabilities changed year-over-year?
- AbbVie's finance lease liabilities decreased by 4.3% year-over-year, from $23M to $22M.
- What is the long-term trend for AbbVie's finance lease liabilities?
- Over 5 years (2020 to 2025), AbbVie's finance lease liabilities has grown at a 0.9% compound annual growth rate (CAGR), from $21M to $22M.
- What does finance lease liabilities mean?
- The total long-term debt obligation resulting from capital leases where the company acts as the owner of the leased asset.
- How do you interpret finance lease liabilities?
- An increase indicates higher long-term debt obligations and potential capital expenditure shifts, while a decrease suggests debt repayment or a shift toward different financing models.
- How does finance lease liabilities compare across companies?
- Comparable to long-term debt obligations found in the non-current liabilities section of peer pharmaceutical companies' balance sheets.